(Q24241069)

English

Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours (English)

0 references

0 references

Kurinchi Selvan Gurusamy

1

0 references

Brian R Davidson

4

object named as

Brian R Davidson

0 references

author name string

Viniyendra Pamecha

2

0 references

Dinesh Sharma

3

0 references

Brian R Davidson

4

0 references

publication date

21 January 2009

0 references

Cochrane Database of Systematic Reviews

0 references

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Hepatic neuroendocrine metastases: does intervention alter outcomes?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Searching the Literatura Latino Americana e do Caribe em Ciências da Saúde (LILACS) database improves systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Methods for combining randomized clinical trials: strengths and limitations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Neuroendocrine tumors. Peptide receptor radionuclide therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Genetics of neuroendocrine and carcinoid tumours

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

A comparison of methods to detect publication bias in meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Intention-to-treat analysis: implications for quantitative and qualitative research

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Surgery in malignant pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Cryotherapeutic ablation of liver tumours

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Metastatic carcinoid tumors: a clinical review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Role of Chemoembolization in Synchronous Liver Metastases from Pancreatic Endocrine Tumours

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Liver transplantation for neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007118.PUB2

21 January 2018

Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of modelling in prioritising and planning clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical treatment of small bowel cancer: A 20-year single institution experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resection versus transplantation for liver metastases from neuroendocrine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19160322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/14651858.CD007118.PUB2

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24241069&oldid=1456542463"